Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias

Details for Australian Patent Application No. 2008324033 (hide)

Owner Asklepius Limited

Inventors Trigiante, Guiseppe

Agent Mallesons

Pub. Number AU-A-2008324033

PCT Pub. Number WO2009/060186

Priority 60/985,496 05.11.07 US

Filing date 5 November 2008

Wipo publication date 14 May 2009

International Classifications

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/7068 (2006.01)

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

3 June 2010 PCT application entered the National Phase

  PCT publication WO2009/060186 Priority application(s): WO2009/060186

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008324045-Anti-VEGF antibody compositions and methods

2008324031-Mycobacterium antigens